Chronic Nerve Pain Has a Power Problem. Scientists Located an Outlet.

Millions of people with chronic nerve pain can't tolerate a light touch. Duke University researchers think they now know why, and the answer isn't in the nerve itself. It's in the batteries.

For years, the assumption has been that when mitochondria, the tiny energy-producing structures inside cells, fail in damaged nerves, that failure is simply part of the injury. The new finding, published in Nature, is that it doesn't have to be.

The researchers uncovered an unexpected role for satellite glial cells, which surround sensory neurons. These glial cells appear to pass mitochondria to neurons through tiny structures known as tunneling nanotubes. In other words, the body already has a delivery system for this. The question was whether you could amplify it.

The answer, in the lab at least, is yes. Using human tissue and mouse models, researchers found that replenishing mitochondria significantly reduced pain tied to diabetic neuropathy and chemotherapy-induced nerve damage, with relief lasting up to 48 hours in some cases. When this energy transfer was boosted, pain behaviors in mice dropped by as much as 50 percent.

Instead of masking symptoms, the approach could fix what the team sees as the root problem: restoring the energy flow that keeps nerve cells healthy and resilient. More work is needed, the scientists said, including high-resolution imaging to confirm precisely how nanotubes help deliver fresh mitochondria to nerve fibers.

Decades of chronic pain treatment have been built around blocking signals. This one is about restoring supply.

Read the full story at ScienceDaily, May 24, 2026

Hot Take: Chronic pain medicine has handed out signal blockers for so long that targeting the actual energy failure underneath feels almost radical. The nerve isn't broken. It's running on empty. That reframe alone is worth more than the 48-hour relief window, because it changes what the next thirty years of treatment design looks like.